Does the application of cryolijm SQ fibrin sealant, for abdominal closure after secondary DIEP flap surgery, leads to a quicker recovery with less complications? A randomized controlled study.

Does the application of cryolijm SQ fibrin sealant, for abdominal closure after secondary DIEP flap surgery, leads to a quicker recovery with less complications? A randomized controlled study. - Cryolijm SQ fibrin sealant application in DIEP flap surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37540

Enrollment

Registered

2012-08-21

Start date

2012-08-31

Completion date

Unknown

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nvt

Interventions

Cryolijm SQ (Sanquin blood supply foundation, Groningen, The Netherlands) is an allogenic single-donor fibrin sealant produced from fresh-frozen quarantined plasma of healthy donors.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female >= 18 years old; Scheduled to undergo an elective DIEP flap breast reconstruction; Provided informed consent Not meet any of the exclusion criteria.

Exclusion criteria

Exclusion criteria: Female

Design outcomes

Primary

Measure	Time frame
Days to drain removal	—

Secondary

Measure	Time frame
1. Total postoperative abdominal drain production 2. Days of hospital admission 3. Abdominal complications and side effects 4. Blood transfusions	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)